## Trustees’ Annual Report and Accounts for the period ending ## 31[st] December 2024 The Ectodermal Dysplasia Society, Unit 1 Maida Vale Business Centre, Maida Vale Road, Cheltenham, Glos. GL53 7ER England Tel: +44 (0) 1242 261332 Mobile: +44 (0) 7774 465712 www.edsociety.co.uk Email: info@edsociety.co.uk ## **Ectodermal Dysplasia Society** ## **Trustees’ Annual Report for the period 1[st] January – 31[st] December 2024** Charity number 1089135 Unit 1, Maida Vale Business Centre, Maida Vale Road, Leckhampton, Cheltenham, GL53 7ER ## **Trustees** Stuart Atkiss Stephen Ayland Nick Briggs Paul Collacott - Chairman Sharon Cooper Scott Gallacher Simon Lee-Jones Larissa Pelham Diana Perry - Chief Executive and Secretary Andy Ponting Alan Waller - Treasurer Martin Williams Elaine Aylward (Irish Representative) Chantelle Epton ## **Administration** Elly Lomas – Accounts Jaye Dix – Family Liaison Danielle Gue – Social Media/Benefits/Website/Marketing & Fundraising Kelly Phelan - Administration ## **Bankers** HSBC Bank, 2, The Promenade, Cheltenham, Gloucestershire, GL50 1LR NatWest, 31 The Promenade, Cheltenham, Glos. GL50 1LE Scottish Widows Bank, 67, Morrison Street, Edinburgh EH3 8YJ ## **Constitution** The Ectodermal Dysplasia Society was formed by a Constitution dated 14[th] July 2001. The Ectodermal Dysplasia Society currently has about 879 contacts. Trustees are appointed at the Annual General Meeting and hold office for a term of up to 3 years. Trustees are able to be reappointed after their period has ended. ## **Objectives** The Ectodermal Dysplasia Society is a charity dedicated to improving the health and wellbeing of people whose lives are affected by the Ectodermal Dysplasias. We work together with people who have Ectodermal Dysplasia, their families, researchers, health and other professionals to develop and share expertise, increase awareness and understanding, and assist with the day-today management of Ectodermal Dysplasia. 1 Although the Ectodermal Dysplasia Society is based in the UK, we support individuals, families and professionals worldwide. Full details of the Ectodermal Dysplasia Society and current activities can be found on the website at www.edsociety.co.uk. ## **Mission (Why we exist)** The Ectodermal Dysplasia Society aims to promote awareness and understanding of the Ectodermal Dysplasias by providing detailed information and practical advice to those individuals and families affected by Ectodermal Dysplasia and to the medical professionals, local authorities and those who support them in living life to the full. The Ectodermal Dysplasia Society aim to: - be the first port of call for all those seeking information on the Ectodermal Dysplasias - provide immediate support to individuals and families who have received an initial diagnosis or who suspect Ectodermal Dysplasia may be the cause of the symptoms - provide personalised support to individuals and families affected by Ectodermal Dysplasia and provide personalised guidance to authorities in the UK (e.g. schools, Social Services) seeking to understand how to manage the effects of Ectodermal Dysplasia on individuals and families in their community - raise the awareness of Ectodermal Dysplasia within the medical profession and other community officials in the UK (e.g., health visitors, social workers) in order to promote early diagnosis of babies and children with life-threatening symptoms of Ectodermal Dysplasia (e.g. overheating, breathing difficulties, feeding difficulties). We have an established Medical Advisory Board of professionals who have the relevant skills to assist us in these aims. ## **Vision (What we want to be)** Our vision is that every individual and family affected by Ectodermal Dysplasia is equipped with the knowledge needed to manage Ectodermal Dysplasia effectively and live life to the full; and that medical professionals have the information and understanding they need to support those affected. The Ectodermal Dysplasia Society seeks to raise funds to provide support services, equipment and grants to families affected by Ectodermal Dysplasia in the UK. ## **Strategy: How We Will Make This Happen** The Ectodermal Dysplasia Society is committed to improving the lives of those affected by Ectodermal Dysplasia. Our work is guided by six key strategic objectives: 1. **Clear Communication** – Providing easily accessible, well-structured information on the different forms of Ectodermal Dysplasia, along with practical guidance on managing symptoms effectively. 2. **Membership & Database Management** – Building and maintaining a comprehensive membership database, including individuals and families affected by Ectodermal Dysplasia, as well as medical professionals with relevant experience and interest in treating the condition. 2 3. **Liaison & Personal Support** – Working closely with individuals, families, professionals, and our Medical Advisory Board to offer tailored advice, support, and advocacy. 4. **Community & Contact Network** – Strengthening connections between families affected by Ectodermal Dysplasia, encouraging a supportive environment for practical and emotional assistance. 5. **Awareness & Education** – Promoting awareness and understanding of Ectodermal Dysplasia within both the medical community and the general public, ensuring better recognition and earlier diagnosis. 6. **Sustainable Fundraising** – Generating financial support to enable the Society to continue providing services, equipment, and grants, ensuring ongoing assistance to those in need. Through these strategic objectives, we aim to enhance the support, treatment, and quality of life for individuals with Ectodermal Dysplasia, while driving awareness and collaboration within the medical community and beyond. ## **Achievements in 2024** ## **Supporting Families & Individuals** - Assisted parents and schools in developing School Care Plans tailored to the management of Ectodermal Dysplasia and attended school meetings. - Helped families with Disability Living Allowance (DLA) and Personal Independent Payment (PIP) applications, writing appeal letters, preparing them for tribunals, and attending these when needed. - Assisted families in obtaining a Blue Badge - Secured rehousing for members seeking help. - Supported and encouraged individuals to fundraise, strengthening our community’s financial sustainability. ## **Research & Medical Collaboration** - Continued working closely with global Ectodermal Dysplasia support leaders, attending regular virtual international meetings. - Supported EspeRare in advancing the ER004 treatment therapy for Ectodermal Dysplasia. - Continued research into temperature regulation and its impact on Ectodermal Dysplasia. - Assisted families in finding specialist dentists through our Dental Network, set up by our Medical Advisory Board. - Attended conferences to gain and share knowledge, including: - British Association of Dermatology (virtual meetings) - European Reference Networks (ERN) & ePAG (virtual meetings) - EDIN (virtual meetings) - Appearance Matters (virtual meetings) - 3 ## **Education, Awareness & Publications** - Delivered presentations to medical organisations to improve awareness and understanding of Ectodermal Dysplasia. - Published and promoted: - “A Guide to Ectodermal Dysplasia” - Children’s book: “Everybody’s Different” (translated into multiple languages). - Began working on a bullying awareness book. - Academic Recognition – Co-authored an article on Ectodermal Dysplasia and climate change, published in _The Lancet_ . - Continued work towards improving resources for the Incontinentia Pigmenti (IP) community. ## **Organisational Growth & Future Planning** - Successfully received grants, including funding from Jeans for Genes. - Applied for and received various additional grants/donations to support our work. - Created a new logo and strapline. - Finalised the redesign of our website for better accessibility and engagement. - Continued planning for the International Ectodermal Dysplasia Conference (Birmingham, June 2025), attending meetings with the Scientific and Organisation Committees. - Worked closely with Trustees on our long-term strategy to ensure sustainability and growth. These achievements reflect our ongoing commitment to supporting families, advancing research, raising awareness, and strengthening our organisation to make a lasting impact. ## **Policy on reserves** - Reserves are maintained at a level which ensures the Ectodermal Dysplasia Society’s core activity can continue during a period of unforeseen difficulty. - A proportion of reserves are to be maintained in a readily realisable form. - The calculation of the required level of reserves is an integral part of the Ectodermal Dysplasia Society’s planning, budget and forecast cycle and takes into account: - Risks associated with each stream of income and expenditure being different from that budgeted - Planned support and research fund - The Ectodermal Dysplasia Society’s commitments. The reserves that we have set aside provide financial stability and the means for the development of our principal activity. We intend to maintain our reserves at a level which is at least equivalent to approximately 75% of our annual expenditure. We intend to use the reserves in the following manner: - a Support fund for the benefit of our members - b Annual Event fund 4 - c Liabilities in the event of closure, redundancy, rent and utility bills. The Trustees annually review the amount of reserves that are required to ensure they are adequate to fulfil our continuing obligations. No funds were in deficit during the period. ## **Income and expenditure** The main source of income is through donations and fundraising. Total receipts in 2024 were £77,208.19 (2023: £62,770.54). We are extremely grateful to our members and others associated with the Ectodermal Dysplasia Society for the generosity of their giving. We are also very grateful to our donors who include: - Jeans for Genes - Next plc The main expenditures are wages and rent, which enable the infrastructure of support provided by the Ectodermal Dysplasia Society. Total outgoing resources in the year were £72,613.57 (2023: £71,228.68). Direct support to individual members is also given and, while allowing the provision of essential equipment such as air-conditioning units, humidifiers, wigs, travel expenses for attending schools and tribunals, etc., represents a lesser proportion of the Ectodermal Dysplasia Society’s outgoings than is applied to verbal advice and moral support. ## **Planned Funding Allocations for 2025** ## **Research & Medical Advancements** - Contribute funding towards the Temperature Regulation Research Programme to improve understanding and treatment options for Ectodermal Dysplasia. ## **Direct Support for Families & Individuals** - Provide financial assistance through the Support Fund, helping families with essential needs. - Support DLA/PIP applications, appeals, and tribunal representation, as well as Blue Badge applications and appeals. - Assist families with school meetings, ensuring that School Care Plans are properly implemented. ## **Awareness, Education & Advocacy** - Host an annual event to bring together families, professionals, and researchers. - Organise and participate in conferences and presentations to spread awareness and educate key stakeholders. - Continue providing guidance and resources to individuals, families, and medical professionals. ## **Digital & Organisational Growth** - Finalise and launch the new ED Society website and contribute to the international EDIN website. 5 - Attend training courses to enhance expertise in social media, fundraising, and benefits assistance. - - Increase marketing and fundraising activities to strengthen financial sustainability. ## **International Ectodermal Dysplasia Conference 2025 (ICED25)** - Continue planning for ICED25 (Birmingham, June 2025), attending Scientific and Organisation Committee meetings to ensure a successful event. These funding priorities align with our mission to support, educate, and advocate for those affected by Ectodermal Dysplasia while ensuring the sustainability of our organisation. Diana Perry Chief Executive and Secretary 22[nd] March 2025 6 ## **Ectodermal Dysplasia Society** ## **Financial Statements** ## **Accounting policies** - 1 The basis of preparation is receipts and payments, with the exception of gift aid, which is recognised as due at the time of the related donation. - 2 Fixed tangible assets with an initial value greater than £1,000 are capitalised. - 3 The General Fund represents funds not subject to any restrictions regarding their use and are available for the general purposes of the charity. The Support Fund represents funds which must be used in accordance with specific restrictions imposed by donors or which have been reserved for particular purposes. 7 ## **ECTODERMAL DYSPLASIA SOCIETY INCOME AND EXPENDITURE ACCOUNT For the year ended 31 December** |**2024**
£
**£**
INCOME Notes
Restricted
funds
Unrestricted
funds
Interest
4.58
999.27
Donations 3
15,139.46
Gift Aid
5,875.41
Members fees
493.02
Fundraising
33,224.27
Christmas Party & Raffle
2,167.48
Merchandise sales 1
256.94
Grants
13,750.00
ICED sponsorship
5,013.84
-
Other income 4
283.92
Total incoming resources
**5,018.42**
**72,189.77**
**EXPENDITURE**
Wages
3,528.90
44,677.99
Postage and Stationery
941.79
Telephone
173.25
Computer related costs
2,023.68
Committee members' expenses
2,276.37
Insurance
566.64
Christmas Party & Raffle
4,651.98
Subscriptions
-
Support for members 2
334.98
-
Rent
7,920.00
Fund Raising and Marketing
Expenses 1
4,757.18
Other expenditure
760.81
Total resources expended
**3,863.88**
**68,749.69**
Net incoming resources before losses on revaluation of overseas
funds
Loss/gain on revaluation of overseas funds 3
Net incoming resources / expenditure
Total funds brought forward
Total funds carried forward|**2023**
**£**
**£**
**£**
Total
404.04
18,347.50
3,932.51
865.09
13,820.39
2,667.60
1,042.44
9,000.00
7,500.00
5,190.97
**77,208.19**
62,770.54
46,007.47
1,553.33
351.09
3,395.28
766.14
519.55
4,115.10
-
1,133.68
7,920.00
4,978.99
488.05
**72,613.57**
71,228.68
**4,594.62**
-8,458.14
-167.90
-124.07
**4,426.72**
-8,582.21
83,890.27
92,472.48
**88,316.99**
83,890.27|**2023**
**£**
**£**
**£**
Total
404.04
18,347.50
3,932.51
865.09
13,820.39
2,667.60
1,042.44
9,000.00
7,500.00
5,190.97
**77,208.19**
62,770.54
46,007.47
1,553.33
351.09
3,395.28
766.14
519.55
4,115.10
-
1,133.68
7,920.00
4,978.99
488.05
**72,613.57**
71,228.68
**4,594.62**
-8,458.14
-167.90
-124.07
**4,426.72**
-8,582.21
83,890.27
92,472.48
**88,316.99**
83,890.27| |---|---|---| |||-8,458.14
-124.07| |||-8,582.21
92,472.48| |||83,890.27| 8 ## **ECTODERMAL DYSPLASIA SOCIETY STATEMENT OF ASSETS AND LIABILITIES As at 31 December** |**ECTODERMAL DYSPLASIA SOCIETY**
**STATEMENT OF ASSETS AND LIABILITIES**
**As at 31 December**|||| |---|---|---|---| |**FIXED ASSETS**
Tangible assets
**CURRENT ASSETS**
Gift Aid due
ICED
NatWest
Scottish Widows Account
Irish Funds (see note 3)
Cash in hand
**CURRENT LIABILITIES**
Creditors
Accrued expenses
**REPRESENTED BY**
General Fund
Restricted funds:
Support Fund
ICED sponsorship|**2024**
**£**
**£**
-
3,159.00
5,724.02
18,867.35
56,331.14
4,204.41
31.07
88,316.99
-
-
-
**88,316.99**
66,489.36
16,067.68
5,759.95
**88,316.99**|**2023**
**£**
**£**
-
2,200.00
3,208.00
8,733.40
65,331.87
4,372.31
44.69
83,890.27
-
-
-
83,890.27
63,217.18
16,398.08
4,275.01
83,890.27|| ||||| ||||83,890.27| ||||63,217.18
16,398.08
4,275.01| ||||83,890.27| These accounts were approved by the Trustees at the Annual General Meeting held on 22nd March 2025 Trustee Trustee 9 ## **ECTODERMAL DYSPLASIA SOCIETY** Notes to the accounts - 1 Merchandise sales represent funds raised through the sale of goods promoting the Society. - 2 Grants received totalled £13,500 (2023: £9,000) and included £750 from Jeans for Genes. - 3 Amounts paid from the Support Fund comprised £334.98 (2023: £1,133.68) in direct support of Members. - 4 The Irish Funds comprise funds held in the Republic of Ireland for the benefit of Members there, but are formally part of the Society’s funds. Net expenditure for the Irish Funds in the current year amounted to £nil (2023: net expenditure of £nil) and the closing balance was £4,204.41 (2023: £4,372.31). Amounts in Euros have been translated at the year-end rate of 1.2060 (2023: 1.1597) Euros to the Pound. The loss on revaluation of funds of £167.89 (2023: loss of £124.07) represents the change in value of the Irish funds resulting in the movement in the Euro exchange rate between the end of 2023 and 2024. - 5 Other income in 2023 included a refund from HMRC of £4,895.26. - 6 There were no outstanding debts or guarantees made by the Ectodermal Dysplasia Society as at 31[st] December 2024 (2023: nil). - 7 Movements in reserves |Opening Balance
Incoming resources
Resources expended
Revaluation
Balance Carried Forward|Restricted
Funds
2024
General
Fund
2024
Total
2024
Restricted
Funds
2023
General
Fund
2023
Total
2023
20,673.09
63,217.18
83,890.27
17,274.28
75,198.20
92,472.48
5,018.42
72,189.77
77,208.19
7,757.48
55,013.06
62,770.54
-3,863.88
-68,749.69
-72,613.57
-4358.67
-66,870.01
-72,228.68
-
-167.90
-167.90
-
-124.07
124.07| |---|---| ||21.827.63
66,489.36
88,316.99
20,673.09
63,217.18
83,890.27| 10 EXAMINER5 UNQUALIFIED REPORT (FOR A NON-COMPANY CHARtm I report on the acts)unts ofthe Trustforthe year ended 31 December 2024. whlth are set out on the attached pages. Re5pe¢tive responsibilitw of trustees and examtner The charity's trustees a￿ responsi1￿e for the preparatKJn of the accounts. The tharitvs trustees consider that an audit is not required for this year Ur￿er section 144(21 of the Charities Act 2011 (the 2011 Act) an(J that an Indepe￿Ient examination is needed. It is my responsTrbilty to: examine the accounts under sect¥)n 145 of the 2011 Art: to follow the procedures laid d(rwn in thÈ general DireCtion$81￿n by the Ctharity Commission under sect￿￿ 14515llbl of the 2011 Art: and Basls of Independent e￿rnIne￿$ ie My examination was Carr￿ out in a¢¢ordano with the genèral t*reLli￿giveft bythe (hrity Commission. An examination indudes a review of the accountin8 records kept bythe tharity arKI a compari50n of the accounts presented with those records. It also indudes consideration of any unusual items or disdosures in the accounts and See￿￿8 explana￿nS from you astrustees con￿mIng any such matters. The procedures undertaken do not provide all the eviden￿ that T*￿￿1d be required in an audit and consequèntly oplnion is 8iven as to whether the accounts present a and fair view. and the report is limited to those rnatters set out in the statenwit below. In conne￿1￿ with my examtnatth. no matter has Come to myattention: Ill whkh gives me reasonable cause to bel*ve that In any materkil respett the requirements: to keep ac¢ountitVd record5 in ar£ordance with section 130 of the 2011 Act: and to prepare accounts which accord with the ac£ounti￿8 records and cornpty with the accounting requirements ofthe 2011 Act have not been met; of 121 to which. in my opin accounts ac n. attention should in orderto enable a proper understaNling of the Name: Willlarn Perry Relevant professwjnal qualification crf body: *nMA Address: 7 Larth Rise. theltenham. Gloucestershtre. GL53 OPY DètÈ- z4fyzr 11